Trials / Recruiting
RecruitingNCT05966675
Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI
Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post Transcatheter Aortic Valve Implantation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Medical University of Silesia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to compare permanent Conduction System Pacing (CSP) with the standard therapy - Right Ventricular Pacing (RVP) or Biventricular Pacing (BVP) - in preventing the development and progression of symptomatic Chronic Heart Failure (CHF) and improving survival in patients after Transcatheter Aortic Valve Implantation (TAVI).
Detailed description
A multicenter randomized controlled head-to-head trial was planned to compare the effects of permanent pacemaker implantation (PPMI) using CSP (study intervention) with currently standard therapy - RVP or BVP (control group). The study population will consist of patients hospitalized after TAVI complicated with high-degree persistent atrioventricular (AV) block or newly developed complex AV or intraventricular conduction disturbances, qualified for PPMI within 30 days after surgery, following the 2021 European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | conduction system pacing | Implantation of cardiac implantable electronic device (CIED) with conduction system pacing (left bundle branch area pacing or his bundle pacing). |
| DEVICE | right ventricular or biventricular pacing | Implantation of cardiac implantable electronic device with right ventricular or biventricular pacing according to left ventricular ejection fraction and current ESC guidelines. |
Timeline
- Start date
- 2024-02-27
- Primary completion
- 2028-05-01
- Completion
- 2028-06-01
- First posted
- 2023-08-01
- Last updated
- 2025-06-08
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT05966675. Inclusion in this directory is not an endorsement.